
LINAC Devices Market Report 2026
Global Outlook – By Product (High Energy, Medium Energy), By Application (Breast Cancer, Colorectal Cancer, Head And Neck Cancer, Lung Cancer, Prostate Cancer, Other Applications), By End User (Clinics, Hospitals) – Market Size, Trends, Strategies, and Forecast to 2035
LINAC Devices Market Overview
• LINAC Devices market size has reached to $5.48 billion in 2025 • Expected to grow to $8.48 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Surge In Cancer Cases Fueling The Growth Of The Market Due To Increasing Demand For Advanced Radiation Therapy • Market Trend: Technological Advancements Unleashed In LINAC Devices Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under LINAC Devices Market?
LINAC stands for linear accelerator, which refers to a device used to accelerate charged particles, such as electrons or protons, in a straight line. LINACs are used in medical settings to produce high-energy electron or X-ray beams for radiation therapy to treat cancer. The main products of LINAC devices are high-energy, low-energy, and medium-energy devices. A high-energy linear accelerator (LINAC) refers to a device that operates at energies of 20-50 million electron volts (MeV) and is used to generate high-energy X-rays or electron beams for radiation therapy for tumors situated deep within the body. Linear accelerator and non-dedicated linear accelerator methods are used for breast cancer, colorectal cancer, head and neck cancer, lung cancer, prostate cancer, and others. It is used by clinics, hospitals, and research center.
What Is The LINAC Devices Market Size and Share 2026?
The linac devices market size has grown strongly in recent years. It will grow from $5.48 billion in 2025 to $5.96 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to expansion of cancer treatment infrastructure, rising global cancer incidence, adoption of advanced radiotherapy techniques, increased availability of oncology specialists, improvements in radiation delivery accuracy.What Is The LINAC Devices Market Growth Forecast?
The linac devices market size is expected to see strong growth in the next few years. It will grow to $8.48 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing investments in precision oncology, growing demand for personalized cancer treatment, advancements in AI-driven radiotherapy planning, expansion of radiotherapy access in emerging markets, rising adoption of compact linac systems. Major trends in the forecast period include increasing adoption of image-guided radiation therapy, rising use of high-energy linac systems, growing integration of ai-based treatment planning, expansion of compact and modular linac designs, enhanced focus on precision dose delivery.Global LINAC Devices Market Segmentation
1) By Product: High Energy, Medium Energy 2) By Application: Breast Cancer, Colorectal Cancer, Head And Neck Cancer, Lung Cancer, Prostate Cancer, Other Applications 3) By End User: Clinics, Hospitals Subsegments: 1) By High Energy: Linear Accelerators For Radiation Therapy, Electron LINACs, Photon LINACs 2) By Medium Energy: Medium Energy Photon LINACs, Compact LINAC SystemsWhat Is The Driver Of The LINAC Devices Market?
The rising prevalence of cancer is expected to propel the growth of the LINAC devices market going forward. Prevalence of cancer refers to the total number of people, both newly diagnosed and previously diagnosed, who are alive with a history of cancer at a specific point in time. The prevalence of cancer is increasing due to lifestyle-related risks such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, elevating the risk of developing various cancers. LINAC devices support cancer management by delivering precise, high-energy radiation beams that target tumors while minimizing damage to surrounding healthy tissues. They improve treatment accuracy, enhance patient outcomes, and enable advanced radiotherapy techniques for more effective cancer care. For instance, in February 2025, according to Cancer Australia, an Australia-based government agency, there were 4,641 new pancreatic cancer cases in 2024, with 2,414 in males and 2,227 in females. Therefore, the rising prevalence of cancer is driving the LINAC devices industry.Key Players In The Global LINAC Devices Market
Major companies operating in the linac devices market are Elekta AB, Varian Medical Systems Inc, Siemens Healthineers GmbH, Hitachi Ltd, Mitsubishi Heavy Industries Ltd, Sumitomo Heavy Industries Ltd, Shinva Medical Instrument Co Ltd, Huiheng Medical Inc, IBA SA, Mevion Medical Systems Inc, ViewRay Technologies Inc, Advanced Oncotherapy PLC, RefleXion Medical Inc, ProNova Solutions LLC, Panacea Medical Technologies Pvt Ltd, Best Theratronics Ltd, P-Cure Ltd, Accuray Incorporated, CGN Dasheng Electron Accelerator Technology Co Ltd, Nordion Inc, Theragenics CorporationGlobal LINAC Devices Market Trends and Insights
Major companies in the LINAC devices market are introducing products based on innovative technologies, such as the ViewRay MRIdian MRI-Guided Radiation Therapy System, to sustain their position in the market. For instance, in March 2023, GenesisCare Pty Ltd., a US-based cancer and cardiac care provider, launched an MRI-guided radiation therapy system at the Lee Health Regional Cancer Center. MRIdian optimizes treatment such that fewer sessions may be necessary by combining precision radiation therapy with cutting-edge, high-resolution MRI guidance. The uniqueness of the product is that it is the first radiotherapy system with diagnostic-quality MRI with an advanced linear accelerator, and provides access to the MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) therapy.What Are Latest Mergers And Acquisitions In The LINAC Devices Market?
In November 2023, AEP Linac, a Netherlands-based of magnetrons and thyratrons used in (medical) linear accelerators, partnered with Alcare for an undisclosed amount to enhance its offerings in radiation therapy solutions. Through this partnership, AEP Linac aims to enhance its offerings in radiation therapy solutions, focusing on integrating Alcare's expertise in patient care products to improve overall treatment experiences. Alcare is a Japan-based company recognized for its innovative solutions designed to support patients' comfort and recovery in medical settings.Regional Outlook
North America was the largest region in the LINAC devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global LINAC devices market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the LINAC Devices Market?
The LINAC devices market consists of sales of an electron generation component, beam transport equipment, radiotherapy equipment, imaging and monitoring accessory. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.LINAC Devices Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $5.96 billion |
| Revenue Forecast In 2035 | $8.48 billion |
| Growth Rate | CAGR of 8.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Elekta AB, Varian Medical Systems Inc, Siemens Healthineers GmbH, Hitachi Ltd, Mitsubishi Heavy Industries Ltd, Sumitomo Heavy Industries Ltd, Shinva Medical Instrument Co Ltd, Huiheng Medical Inc, IBA SA, Mevion Medical Systems Inc, ViewRay Technologies Inc, Advanced Oncotherapy PLC, RefleXion Medical Inc, ProNova Solutions LLC, Panacea Medical Technologies Pvt Ltd, Best Theratronics Ltd, P-Cure Ltd, Accuray Incorporated, CGN Dasheng Electron Accelerator Technology Co Ltd, Nordion Inc, Theragenics Corporation |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
